NeuroSense Therapeutics Statistics
Total Valuation
NRSN has a market cap or net worth of $13.20 million. The enterprise value is $10.63 million.
| Market Cap | 13.20M |
| Enterprise Value | 10.63M |
Important Dates
The next estimated earnings date is Wednesday, August 14, 2024, before market open.
| Earnings Date | Aug 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NRSN has 18.04 million shares outstanding. The number of shares has increased by 18.56% in one year.
| Shares Outstanding | 18.04M |
| Shares Change (YoY) | +18.56% |
| Shares Change (QoQ) | +9.43% |
| Owned by Insiders (%) | 27.45% |
| Owned by Institutions (%) | 1.13% |
| Float | 11.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.84
| Current Ratio | 0.84 |
| Quick Ratio | 0.83 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -185.70% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$561,500 |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.08% in the last 52 weeks. The beta is 1.50, so NRSN's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | -48.08% |
| 50-Day Moving Average | 1.06 |
| 200-Day Moving Average | 1.09 |
| Relative Strength Index (RSI) | 33.77 |
| Average Volume (20 Days) | 539,969 |
Short Selling Information
The latest short interest is 17,910, so 0.10% of the outstanding shares have been sold short.
| Short Interest | 17,910 |
| Short Previous Month | 8,075 |
| Short % of Shares Out | 0.10% |
| Short % of Float | 0.16% |
| Short Ratio (days to cover) | 0.16 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.05M |
| Pretax Income | -10.11M |
| Net Income | -10.11M |
| EBITDA | -10.09M |
| EBIT | -10.11M |
| Earnings Per Share (EPS) | -$0.74 |
Balance Sheet
The company has $2.64 million in cash and $73,000 in debt, giving a net cash position of $2.57 million or $0.14 per share.
| Cash & Cash Equivalents | 2.64M |
| Total Debt | 73,000 |
| Net Cash | 2.57M |
| Net Cash Per Share | $0.14 |
| Equity (Book Value) | -1.76M |
| Book Value Per Share | -0.10 |
| Working Capital | -543,000 |
Cash Flow
In the last 12 months, operating cash flow was -$8.35 million and capital expenditures -$29,000, giving a free cash flow of -$8.38 million.
| Operating Cash Flow | -8.35M |
| Capital Expenditures | -29,000 |
| Free Cash Flow | -8.38M |
| FCF Per Share | -$0.62 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NRSN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.56% |
| Shareholder Yield | -18.56% |
| Earnings Yield | -76.59% |
| FCF Yield | -63.53% |
Analyst Forecast
The average price target for NRSN is $7.50, which is 925.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.50 |
| Price Target Difference | 925.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |